technetium has been researched along with Cardiac Toxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattarai, P; Gada, K; Khaw, BA; Majewski, S; Panwar, R; Patil, V | 1 |
| Mariani, G; Strauss, HW | 1 |
2 other study(ies) available for technetium and Cardiac Toxicity
| Article | Year |
|---|---|
Imaging doxorubicin and polymer-drug conjugates of doxorubicin-induced cardiotoxicity with bispecific anti-myosin-anti-DTPA antibody and Tc-99m-labeled polymers.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Bispecific; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Male; Mice; Mice, Inbred BALB C; Pentetic Acid; Polymers; Technetium; Tomography, Emission-Computed, Single-Photon | 2019 |
Detection of chemotherapy-induced cardiotoxicity with antimyosin pretargeted imaging.
Topics: Antineoplastic Agents; Cardiotoxicity; Doxorubicin; Humans; Polymers; Technetium | 2019 |